Testosterone Information Androderm®

Feedback | A-Z Index

Contact Details Site Map Page


Testosterone Index

About Us | Quick Reference | Information | Real Lives | Library | Publications | Other Links | Contact Us

About Us


Quick Ref

Information

Real Lives

Online Library

Publications

Other LInks

Contact Us

pdf document Androderm® — consumer medicines information. (Mayne Pharma PDF)

Description

  • 12.2 mg (releasing approximately 2.5 mg per 24 hours), 60
  • 4.3 mg (releasing approximately 5 mg per 24 hours), 30.
  • Androderm® is a transdermal drug delivery system consisting of a self adhesive patch surrounding a central drug reservoir of testosterone dissolved in an alcohol-based gel. Androderm® contains only testosterone which is identical to the naturally occurring testosterone present in the body.
  • Manufactured by Mayne Pharma Pty Ltd (David Bull Laboratories, Faulding Pharmaceuticals).

Availability

A doctor's prescription is required to obtain this medication.

General Information

  • Androderm® is usually applied at night and worn for 24 hours. Most men will need to wear two 2.5 mg patches. The patches are applied to the back, arms, shoulders, abdomen or buttocks. Never apply the patch to the scrotum (surgically constructed or natal).
  • Measurement of serum testosterone should be repeated taking care to ensure proper patch adhesion and correct time of application before the dose is adjusted.
  • Three patches per day may be required for men with a higher body weight (>130kg).
  • The duration of treatment and frequency of testosterone measurements is determined by the physician.
  • Approx. 10% of men experience skin irritation which include mild to moderate inflammation, roughened skin or burning; allergic, itchy and sometimes blistering skin reactions.

Australian PBS

Authority required when prescribed to males through the Australian PBS.
Androgen deficiency in males with established pituitary or testicular disorders
Androgen deficiency in males 40 years and older who do not have established pituitary or testicular disorders other than aging, confirmed by at least 2 morning blood samples taken on different mornings. Androgen deficiency is confirmed by testosterone less than 8 nmol per L, or 8-15 nmol per L with high LH (greater than 1.5 times the upper limit of the eugonadal reference range for young men).
Micropenis, pubertal induction, or constitutional delay of growth or puberty, in males under 18 years of age.

Further reading about Androderm

The information contained on this page is not medical advice. Medical advice is dependent upon the specific circumstances of each individual. Please consult with qualified medical professionals for your personal situation.

Testosterone Index

click here to return to the Home page
"Resources for transition and beyond in Australia"

Copyright © FTM Australia (MTRA). all rights reserved | Webmanager - Citing this Website

page revised - 14 April 2007

top